In addition to these metabolic effects, we noted that OXT treatment tended to improve blood glucose and insulin homeostasis; under this scope, while clinical studies based on diabetic patients are needed, we employed mouse models to examine if OXT could use treat diabetes. This evidence concerns the gene INS and diabetes mellitus.